
Michael B. Pallay
Examiner (ID: 8823, Phone: (571)270-3473 , Office: P/1617 )
| Most Active Art Unit | 1617 |
| Art Unit(s) | 1617 |
| Total Applications | 915 |
| Issued Applications | 441 |
| Pending Applications | 107 |
| Abandoned Applications | 386 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 13424759
[patent_doc_number] => 20180263922
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-09-20
[patent_title] => TRANSDERMAL DELIVERY SYSTEM CONTAINING METHYLPHENIDATE OR ITS SALTS AND METHODS THEREOF
[patent_app_type] => utility
[patent_app_number] => 15/961112
[patent_app_country] => US
[patent_app_date] => 2018-04-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12440
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15961112
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/961112 | Transdermal delivery system containing methylphenidate or its salts and methods thereof | Apr 23, 2018 | Issued |
Array
(
[id] => 13368701
[patent_doc_number] => 20180235891
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-08-23
[patent_title] => NON-GELATIN ENTERIC SOFT CAPSULES
[patent_app_type] => utility
[patent_app_number] => 15/959645
[patent_app_country] => US
[patent_app_date] => 2018-04-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9853
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 113
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15959645
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/959645 | Non-gelatin enteric soft capsules | Apr 22, 2018 | Issued |
Array
(
[id] => 13372419
[patent_doc_number] => 20180237750
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-08-23
[patent_title] => CELL CULTURE METHOD USING BONE MARROW-LIKE STRUCTURE, AND POROUS POLYIMIDE FILM FOR HEALING BONE INJURY SITE
[patent_app_type] => utility
[patent_app_number] => 15/958995
[patent_app_country] => US
[patent_app_date] => 2018-04-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13819
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 110
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15958995
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/958995 | Cell culture method using bone marrow-like structure, and porous polyimide film for healing bone injury site | Apr 19, 2018 | Issued |
Array
(
[id] => 15765617
[patent_doc_number] => 20200113826
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-04-16
[patent_title] => SUSPENSION COMPRISING ALUMINUM HYDROXIDE AND MAGNESIUM HYDROXIDE AND PREPARATION METHOD THEREFOR
[patent_app_type] => utility
[patent_app_number] => 16/604167
[patent_app_country] => US
[patent_app_date] => 2018-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4241
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16604167
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/604167 | Suspension comprising aluminum hydroxide and magnesium hydroxide and preparation method therefor | Apr 11, 2018 | Issued |
Array
(
[id] => 13440467
[patent_doc_number] => 20180271776
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-09-27
[patent_title] => Hydrogen-Generating Effervescent Tablet and Methods Thereof
[patent_app_type] => utility
[patent_app_number] => 15/938444
[patent_app_country] => US
[patent_app_date] => 2018-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2252
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15938444
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/938444 | Hydrogen-Generating Effervescent Tablet and Methods Thereof | Mar 27, 2018 | Abandoned |
Array
(
[id] => 16998452
[patent_doc_number] => 11077234
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-08-03
[patent_title] => Antimicrobial coatings for medical implements and medical devices
[patent_app_type] => utility
[patent_app_number] => 15/938417
[patent_app_country] => US
[patent_app_date] => 2018-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18765
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 118
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15938417
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/938417 | Antimicrobial coatings for medical implements and medical devices | Mar 27, 2018 | Issued |
Array
(
[id] => 18353966
[patent_doc_number] => 11642350
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-05-09
[patent_title] => Agent for preventing myopia, treating myopia, and/or preventing myopia progression comprising tiotropium as active ingredient
[patent_app_type] => utility
[patent_app_number] => 16/495350
[patent_app_country] => US
[patent_app_date] => 2018-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4967
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 86
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16495350
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/495350 | Agent for preventing myopia, treating myopia, and/or preventing myopia progression comprising tiotropium as active ingredient | Mar 21, 2018 | Issued |
Array
(
[id] => 13440983
[patent_doc_number] => 20180272034
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-09-27
[patent_title] => USE OF CSA COMPOUNDS TO PREVENT MICROBIAL BUILD-UP OR FOULING OF MEDICAL IMPLANTS
[patent_app_type] => utility
[patent_app_number] => 15/926577
[patent_app_country] => US
[patent_app_date] => 2018-03-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9632
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15926577
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/926577 | USE OF CSA COMPOUNDS TO PREVENT MICROBIAL BUILD-UP OR FOULING OF MEDICAL IMPLANTS | Mar 19, 2018 | Abandoned |
Array
(
[id] => 13425251
[patent_doc_number] => 20180264168
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-09-20
[patent_title] => COMPOSITION MATERIAL AND METHOD FOR FREE FORMING BONE SUBSTITUTE
[patent_app_type] => utility
[patent_app_number] => 15/920470
[patent_app_country] => US
[patent_app_date] => 2018-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3699
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15920470
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/920470 | Composition material and method for free forming bone substitute | Mar 13, 2018 | Issued |
Array
(
[id] => 14609571
[patent_doc_number] => 10357463
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-07-23
[patent_title] => Rivastigmine transdermal compositions and methods of using the same
[patent_app_type] => utility
[patent_app_number] => 15/917478
[patent_app_country] => US
[patent_app_date] => 2018-03-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 15
[patent_no_of_words] => 12541
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15917478
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/917478 | Rivastigmine transdermal compositions and methods of using the same | Mar 8, 2018 | Issued |
Array
(
[id] => 12904372
[patent_doc_number] => 20180193299
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-07-12
[patent_title] => ORAL PHARMACEUTICAL COMPOSITION OF ISOTRETINOIN
[patent_app_type] => utility
[patent_app_number] => 15/913368
[patent_app_country] => US
[patent_app_date] => 2018-03-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4526
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15913368
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/913368 | ORAL PHARMACEUTICAL COMPOSITION OF ISOTRETINOIN | Mar 5, 2018 | Abandoned |
Array
(
[id] => 12806530
[patent_doc_number] => 20180160680
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-06-14
[patent_title] => METHODS AND COMPOSITIONS FOR USE WITH GEL DISPENSERS
[patent_app_type] => utility
[patent_app_number] => 15/893817
[patent_app_country] => US
[patent_app_date] => 2018-02-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6693
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 118
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15893817
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/893817 | Methods and compositions for use with gel dispensers | Feb 11, 2018 | Issued |
Array
(
[id] => 14257693
[patent_doc_number] => 10278388
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-05-07
[patent_title] => Methods and compositions for use with gel dispensers
[patent_app_type] => utility
[patent_app_number] => 15/893825
[patent_app_country] => US
[patent_app_date] => 2018-02-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6692
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 76
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15893825
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/893825 | Methods and compositions for use with gel dispensers | Feb 11, 2018 | Issued |
Array
(
[id] => 13926347
[patent_doc_number] => 20190046689
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-02-14
[patent_title] => Wet-Electrospun Biodegradable Scaffold and Uses Therefor
[patent_app_type] => utility
[patent_app_number] => 15/892481
[patent_app_country] => US
[patent_app_date] => 2018-02-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15055
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 95
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15892481
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/892481 | Wet-Electrospun Biodegradable Scaffold and Uses Therefor | Feb 8, 2018 | Abandoned |
Array
(
[id] => 15147411
[patent_doc_number] => 20190352183
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-11-21
[patent_title] => NANOCARBON-IRON COMPOSITE SYSTEM AS WELL AS COMPOSITION, PREPARATION METHOD AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/480567
[patent_app_country] => US
[patent_app_date] => 2018-01-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17590
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16480567
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/480567 | Nanocarbon-iron composite system as well as composition, preparation method and use thereof | Jan 25, 2018 | Issued |
Array
(
[id] => 12857689
[patent_doc_number] => 20180177737
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-06-28
[patent_title] => INSTRUMENT FOR SKIN TREATMENT
[patent_app_type] => utility
[patent_app_number] => 15/850362
[patent_app_country] => US
[patent_app_date] => 2017-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6172
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15850362
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/850362 | Instrument for skin treatment | Dec 20, 2017 | Issued |
Array
(
[id] => 14467557
[patent_doc_number] => 20190185421
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-06-20
[patent_title] => METHOD FOR PRODUCING ACTIVE INGREDIENT FOR RIVASTIGMINE FREE BASE TRANSDERMAL PATCH AND RIVASTIGMINE FREE BASE TRANSDERMAL PATCH COMPRISING THE SAME
[patent_app_type] => utility
[patent_app_number] => 15/842117
[patent_app_country] => US
[patent_app_date] => 2017-12-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3585
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15842117
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/842117 | Method for producing active ingredient for rivastigmine free base transdermal patch and rivastigmine free base transdermal patch comprising the same | Dec 13, 2017 | Issued |
Array
(
[id] => 15862569
[patent_doc_number] => 20200138688
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-05-07
[patent_title] => Composition For Enhancing Protein Strength
[patent_app_type] => utility
[patent_app_number] => 16/477047
[patent_app_country] => US
[patent_app_date] => 2017-12-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7442
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16477047
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/477047 | Composition For Enhancing Protein Strength | Dec 11, 2017 | Abandoned |
Array
(
[id] => 12580407
[patent_doc_number] => 20180085298
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-03-29
[patent_title] => COMPOSITIONS, KITS AND METHODS FOR MAINTAINING EYELID HYGIENE
[patent_app_type] => utility
[patent_app_number] => 15/830428
[patent_app_country] => US
[patent_app_date] => 2017-12-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4217
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15830428
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/830428 | Compositions, kits and methods for maintaining eyelid hygiene | Dec 3, 2017 | Issued |
Array
(
[id] => 12580485
[patent_doc_number] => 20180085324
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-03-29
[patent_title] => TOPICAL SANITIZER THAT INCLUDES AVENANTHRAMIDES
[patent_app_type] => utility
[patent_app_number] => 15/828490
[patent_app_country] => US
[patent_app_date] => 2017-12-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6802
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 82
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15828490
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/828490 | TOPICAL SANITIZER THAT INCLUDES AVENANTHRAMIDES | Nov 30, 2017 | Abandoned |